ENTITY
Shanghai Fosun Pharmaceutical (Group)

Shanghai Fosun Pharmaceutical (Group) (600196 CH)

75
Analysis
Health CareChina
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is a pharmaceutical company. Through its subsidiaries, the Company manufactures genetic medicines, Chinese traditional medicines, diagnostic products, and medical instruments, provides technology, marketing, and advertising services, as well as invests in import and export trading.
more
17 Dec 2018 11:06

Discover HK Connect: Mainlanders Are Buying Shandong Gold, and Pharmaceuticals (2018-12-17)

In our Discover HK Connect series, we aim to help our investors understand the flow of southbound trades via the Hong Kong Connect, as analyzed by...

Logo
457 Views
Share
bearishWuXi AppTec
28 Nov 2018 05:57

WuXi AppTech IPO Update: Figuring Out the Right AH Premium

WuXi AppTec Co. Ltd. (WUXI HK) is a leading global pharmaceutical R&D outsourcing service provider and the largest in Asia by revenue in 2017....

Logo
722 Views
Share
21 Oct 2018 08:51

Last Week in Event SPACE: Spring REIT, Alps/Alpine, NTT, JCNC, Restaurant Brands, A/H

Last Week in Event SPACE ... A previously non-disclosed connected party tarnishes a property acquisition and bolsters PAG's Offer for Spring Real...

Logo
501 Views
Share
22 Jul 2018 16:09

Ascletis Pharma IPO Preview: Drug-Fuelled Euphoria Needed to Justify Valuation

Ascletis Pharma Inc (AP HK) which specialises in developing drugs to treat HCV (hepatitis C virus), HIV and liver cancer, is the first pre-profit...

Logo
758 Views
Share
03 Jul 2018 12:26

Quiddity Weekly H/A: Spread Monitor & Southbound Flows [Week to 29 Jun 2018]

An H/A Spread Monitor Project offering a brief look at recent changes in H-Share and A-Share spreads, Southbound flow and impact, and where the...

Logo
253 Views
Share
x